img

Global and India Prilide Antihypertensive Drugs Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and India Prilide Antihypertensive Drugs Market Report & Forecast 2024-2034

Market Analysis and InsightsGlobal and India Prilide Antihypertensive Drugs Market
This report focuses on global and India Prilide Antihypertensive Drugs market, also covers the segmentation data of other regions in regional level and county level.
The global Prilide Antihypertensive Drugs revenue was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period (2024-2034).
In India the Prilide Antihypertensive Drugs revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period (2024-2034).
The global key players of Prilide Antihypertensive Drugs include Merck, Pfizer, Sanofi, Abbott, Novartis, Changzhou Pharmaceutical, Humanwell Pharmaceutical, Hengcheng Pharmaceutical and Hengwei Pharmaceutical, etc. The global five biggest players hold a share of % in 2024.
Global Prilide Antihypertensive Drugs Scope and Market Size
Prilide Antihypertensive Drugs market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Prilide Antihypertensive Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2034.
For India market, this report focuses on the Prilide Antihypertensive Drugs market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in India.



By Company


Merck
Pfizer
Sanofi
Abbott
Novartis
Changzhou Pharmaceutical
Humanwell Pharmaceutical
Hengcheng Pharmaceutical
Hengwei Pharmaceutical
Zhongfu Pharmaceutical
Likang Pharmaceutical
Changjiang Pharmaceutical
Baiyunshan Pharmaceutical
Poly Pharm
Lukang Group
Baili Pharmaceutical
Huahai Pharmaceutical
Segment by Type
Captopril
Enalapril
Lisinopril
Fosinopril
Others

Segment by Application


Hospital
Clinic
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Prilide Antihypertensive Drugs definition, global sales (volume and revenue), India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Prilide Antihypertensive Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Prilide Antihypertensive Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prilide Antihypertensive Drugs sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion

Table of Content

1 Study Coverage
1.1 Prilide Antihypertensive Drugs Product Introduction
1.2 Global Prilide Antihypertensive Drugs Outlook 2018 VS 2024 VS 2034
1.2.1 Global Prilide Antihypertensive Drugs Sales in US$ Million for the Year 2018-2034
1.2.2 Global Prilide Antihypertensive Drugs Sales in Volume for the Year 2018-2034
1.3 India Prilide Antihypertensive Drugs Outlook 2018 VS 2024 VS 2034
1.3.1 India Prilide Antihypertensive Drugs Sales in US$ Million for the Year 2018-2034
1.3.2 India Prilide Antihypertensive Drugs Sales in Volume for the Year 2018-2034
1.4 Prilide Antihypertensive Drugs Market Size, India VS Global, 2018 VS 2024 VS 2034
1.4.1 The Market Share of India Prilide Antihypertensive Drugs in Global, 2018 VS 2024 VS 2034
1.4.2 The Growth Rate of Prilide Antihypertensive Drugs Market Size, India VS Global, 2018 VS 2024 VS 2034
1.5 Prilide Antihypertensive Drugs Market Dynamics
1.5.1 Prilide Antihypertensive Drugs Industry Trends
1.5.2 Prilide Antihypertensive Drugs Market Drivers
1.5.3 Prilide Antihypertensive Drugs Market Challenges
1.5.4 Prilide Antihypertensive Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Prilide Antihypertensive Drugs by Type
2.1 Prilide Antihypertensive Drugs Market Segment by Type
2.1.1 Captopril
2.1.2 Enalapril
2.1.3 Lisinopril
2.1.4 Fosinopril
2.1.5 Others
2.2 Global Prilide Antihypertensive Drugs Market Size by Type
2.2.1 Global Prilide Antihypertensive Drugs Sales in Value, by Type (2018, 2024 & 2034)
2.2.2 Global Prilide Antihypertensive Drugs Sales in Volume, by Type (2018, 2024 & 2034)
2.2.3 Global Prilide Antihypertensive Drugs Average Selling Price (ASP) by Type (2018, 2024 & 2034)
2.3 India Prilide Antihypertensive Drugs Market Size by Type
2.3.1 India Prilide Antihypertensive Drugs Sales in Value, by Type (2018, 2024 & 2034)
2.3.2 India Prilide Antihypertensive Drugs Sales in Volume, by Type (2018, 2024 & 2034)
2.3.3 India Prilide Antihypertensive Drugs Average Selling Price (ASP) by Type (2018, 2024 & 2034)
3 Prilide Antihypertensive Drugs by Application
3.1 Prilide Antihypertensive Drugs Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.2 Global Prilide Antihypertensive Drugs Market Size by Application
3.2.1 Global Prilide Antihypertensive Drugs Sales in Value, by Application (2018, 2024 & 2034)
3.2.2 Global Prilide Antihypertensive Drugs Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 Global Prilide Antihypertensive Drugs Average Selling Price (ASP) by Application (2018, 2024 & 2034)
3.3 India Prilide Antihypertensive Drugs Market Size by Application
3.3.1 India Prilide Antihypertensive Drugs Sales in Value, by Application (2018, 2024 & 2034)
3.3.2 India Prilide Antihypertensive Drugs Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 India Prilide Antihypertensive Drugs Average Selling Price (ASP) by Application (2018, 2024 & 2034)
4 Global Prilide Antihypertensive Drugs Competitor Landscape by Company
4.1 Global Prilide Antihypertensive Drugs Market Size by Company
4.1.1 Global Key Manufacturers of Prilide Antihypertensive Drugs, Ranked by Revenue (2024)
4.1.2 Global Prilide Antihypertensive Drugs Revenue by Manufacturer (2018-2023)
4.1.3 Global Prilide Antihypertensive Drugs Sales by Manufacturer (2018-2023)
4.1.4 Global Prilide Antihypertensive Drugs Price by Manufacturer (2018-2023)
4.2 Global Prilide Antihypertensive Drugs Concentration Ratio (CR)
4.2.1 Prilide Antihypertensive Drugs Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Prilide Antihypertensive Drugs in 2024
4.2.3 Global Prilide Antihypertensive Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Prilide Antihypertensive Drugs, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Prilide Antihypertensive Drugs, Product Offered and Application
4.5 Global Key Manufacturers of Prilide Antihypertensive Drugs, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India Prilide Antihypertensive Drugs Market Size by Company
4.7.1 Key Players of Prilide Antihypertensive Drugs in India, Ranked by Revenue (2024)
4.7.2 India Prilide Antihypertensive Drugs Revenue by Players (2018-2023)
4.7.3 India Prilide Antihypertensive Drugs Sales by Players (2018-2023)
5 Global Prilide Antihypertensive Drugs Market Size by Region
5.1 Global Prilide Antihypertensive Drugs Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Prilide Antihypertensive Drugs Market Size in Volume by Region (2018-2034)
5.2.1 Global Prilide Antihypertensive Drugs Sales in Volume by Region: 2018-2023
5.2.2 Global Prilide Antihypertensive Drugs Sales in Volume Forecast by Region (2024-2034)
5.3 Global Prilide Antihypertensive Drugs Market Size in Value by Region (2018-2034)
5.3.1 Global Prilide Antihypertensive Drugs Sales in Value by Region: 2018-2023
5.3.2 Global Prilide Antihypertensive Drugs Sales in Value by Region: 2024-2034
6 Americas
6.1 Americas Prilide Antihypertensive Drugs Market Size YoY Growth 2018-2034
6.2 Americas Prilide Antihypertensive Drugs Sales in Volume, by Type (2018, 2024 & 2034)
6.3 Americas Prilide Antihypertensive Drugs Sales in Volume, by Application (2018, 2024 & 2034)
6.4 Americas Prilide Antihypertensive Drugs Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 Americas Prilide Antihypertensive Drugs Sales in Value by Country (2018, 2024 & 2034)
6.4.2 Americas Prilide Antihypertensive Drugs Sales in Volume by Country (2018, 2024 & 2034)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Prilide Antihypertensive Drugs Market Size YoY Growth 2018-2034
7.2 EMEA Prilide Antihypertensive Drugs Sales in Volume, by Type (2018, 2024 & 2034)
7.3 EMEA Prilide Antihypertensive Drugs Sales in Volume, by Application (2018, 2024 & 2034)
7.4 EMEA Prilide Antihypertensive Drugs Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 EMEA Prilide Antihypertensive Drugs Sales in Value by Country (2018, 2024 & 2034)
7.4.2 EMEA Prilide Antihypertensive Drugs Sales in Volume by Country (2018, 2024 & 2034)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Prilide Antihypertensive Drugs Market Size YoY Growth 2018-2034
8.2 China Prilide Antihypertensive Drugs Sales in Volume, by Type (2018, 2024 & 2034)
8.3 China Prilide Antihypertensive Drugs Sales in Volume, by Application (2018, 2024 & 2034)
9 APAC
9.1 APAC Prilide Antihypertensive Drugs Market Size YoY Growth 2018-2034
9.2 APAC Prilide Antihypertensive Drugs Sales in Volume, by Type (2018, 2024 & 2034)
9.3 APAC Prilide Antihypertensive Drugs Sales in Volume, by Application (2018, 2024 & 2034)
9.4 APAC Prilide Antihypertensive Drugs Market Facts & Figures by Region (2018, 2024 & 2034)
9.4.1 APAC Prilide Antihypertensive Drugs Sales in Value by Region (2018, 2024 & 2034)
9.4.2 APAC Prilide Antihypertensive Drugs Sales in Volume by Region (2018, 2024 & 2034)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Description and Business Overview
10.1.3 Merck Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck Prilide Antihypertensive Drugs Products Offered
10.1.5 Merck Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Information
10.2.2 Pfizer Description and Business Overview
10.2.3 Pfizer Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Pfizer Prilide Antihypertensive Drugs Products Offered
10.2.5 Pfizer Recent Development
10.3 Sanofi
10.3.1 Sanofi Company Information
10.3.2 Sanofi Description and Business Overview
10.3.3 Sanofi Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Sanofi Prilide Antihypertensive Drugs Products Offered
10.3.5 Sanofi Recent Development
10.4 Abbott
10.4.1 Abbott Company Information
10.4.2 Abbott Description and Business Overview
10.4.3 Abbott Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Abbott Prilide Antihypertensive Drugs Products Offered
10.4.5 Abbott Recent Development
10.5 Novartis
10.5.1 Novartis Company Information
10.5.2 Novartis Description and Business Overview
10.5.3 Novartis Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Novartis Prilide Antihypertensive Drugs Products Offered
10.5.5 Novartis Recent Development
10.6 Changzhou Pharmaceutical
10.6.1 Changzhou Pharmaceutical Company Information
10.6.2 Changzhou Pharmaceutical Description and Business Overview
10.6.3 Changzhou Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Changzhou Pharmaceutical Prilide Antihypertensive Drugs Products Offered
10.6.5 Changzhou Pharmaceutical Recent Development
10.7 Humanwell Pharmaceutical
10.7.1 Humanwell Pharmaceutical Company Information
10.7.2 Humanwell Pharmaceutical Description and Business Overview
10.7.3 Humanwell Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Humanwell Pharmaceutical Prilide Antihypertensive Drugs Products Offered
10.7.5 Humanwell Pharmaceutical Recent Development
10.8 Hengcheng Pharmaceutical
10.8.1 Hengcheng Pharmaceutical Company Information
10.8.2 Hengcheng Pharmaceutical Description and Business Overview
10.8.3 Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Products Offered
10.8.5 Hengcheng Pharmaceutical Recent Development
10.9 Hengwei Pharmaceutical
10.9.1 Hengwei Pharmaceutical Company Information
10.9.2 Hengwei Pharmaceutical Description and Business Overview
10.9.3 Hengwei Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Hengwei Pharmaceutical Prilide Antihypertensive Drugs Products Offered
10.9.5 Hengwei Pharmaceutical Recent Development
10.10 Zhongfu Pharmaceutical
10.10.1 Zhongfu Pharmaceutical Company Information
10.10.2 Zhongfu Pharmaceutical Description and Business Overview
10.10.3 Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Products Offered
10.10.5 Zhongfu Pharmaceutical Recent Development
10.11 Likang Pharmaceutical
10.11.1 Likang Pharmaceutical Company Information
10.11.2 Likang Pharmaceutical Description and Business Overview
10.11.3 Likang Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Likang Pharmaceutical Prilide Antihypertensive Drugs Products Offered
10.11.5 Likang Pharmaceutical Recent Development
10.12 Changjiang Pharmaceutical
10.12.1 Changjiang Pharmaceutical Company Information
10.12.2 Changjiang Pharmaceutical Description and Business Overview
10.12.3 Changjiang Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Changjiang Pharmaceutical Prilide Antihypertensive Drugs Products Offered
10.12.5 Changjiang Pharmaceutical Recent Development
10.13 Baiyunshan Pharmaceutical
10.13.1 Baiyunshan Pharmaceutical Company Information
10.13.2 Baiyunshan Pharmaceutical Description and Business Overview
10.13.3 Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Products Offered
10.13.5 Baiyunshan Pharmaceutical Recent Development
10.14 Poly Pharm
10.14.1 Poly Pharm Company Information
10.14.2 Poly Pharm Description and Business Overview
10.14.3 Poly Pharm Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Poly Pharm Prilide Antihypertensive Drugs Products Offered
10.14.5 Poly Pharm Recent Development
10.15 Lukang Group
10.15.1 Lukang Group Company Information
10.15.2 Lukang Group Description and Business Overview
10.15.3 Lukang Group Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Lukang Group Prilide Antihypertensive Drugs Products Offered
10.15.5 Lukang Group Recent Development
10.16 Baili Pharmaceutical
10.16.1 Baili Pharmaceutical Company Information
10.16.2 Baili Pharmaceutical Description and Business Overview
10.16.3 Baili Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Baili Pharmaceutical Prilide Antihypertensive Drugs Products Offered
10.16.5 Baili Pharmaceutical Recent Development
10.17 Huahai Pharmaceutical
10.17.1 Huahai Pharmaceutical Company Information
10.17.2 Huahai Pharmaceutical Description and Business Overview
10.17.3 Huahai Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Huahai Pharmaceutical Prilide Antihypertensive Drugs Products Offered
10.17.5 Huahai Pharmaceutical Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Prilide Antihypertensive Drugs Industry Chain Analysis
11.2 Prilide Antihypertensive Drugs Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Prilide Antihypertensive Drugs Production Mode & Process
11.4 Prilide Antihypertensive Drugs Sales and Marketing
11.4.1 Prilide Antihypertensive Drugs Sales Channels
11.4.2 Prilide Antihypertensive Drugs Distributors
11.5 Prilide Antihypertensive Drugs Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Prilide Antihypertensive Drugs CAGR in Value, India VS Global, 2018 VS 2024 VS 2034
Table 2. Prilide Antihypertensive Drugs Market Trends
Table 3. Prilide Antihypertensive Drugs Market Drivers
Table 4. Prilide Antihypertensive Drugs Market Challenges
Table 5. Prilide Antihypertensive Drugs Market Restraints
Table 6. Global Prilide Antihypertensive Drugs Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. India Prilide Antihypertensive Drugs Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Prilide Antihypertensive Drugs Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. India Prilide Antihypertensive Drugs Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Manufacturers of Prilide Antihypertensive Drugs, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Prilide Antihypertensive Drugs Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Prilide Antihypertensive Drugs Revenue Share by Manufacturer, 2018-2023
Table 13. Global Prilide Antihypertensive Drugs Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global Prilide Antihypertensive Drugs Sales Share by Manufacturer, 2018-2023
Table 15. Global Prilide Antihypertensive Drugs Price by Manufacturer (2018-2023) & (US$/Unit)
Table 16. Global Prilide Antihypertensive Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Prilide Antihypertensive Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prilide Antihypertensive Drugs as of 2024)
Table 18. Global Key Manufacturers of Prilide Antihypertensive Drugs, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Prilide Antihypertensive Drugs, Product Offered and Application
Table 20. Global Key Manufacturers of Prilide Antihypertensive Drugs, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Prilide Antihypertensive Drugs in India, Ranked by Revenue (2024) & (US$ million)
Table 23. India Prilide Antihypertensive Drugs Revenue by Players, (US$ Million), (2018-2023)
Table 24. India Prilide Antihypertensive Drugs Revenue Share by Players, (2018-2023)
Table 25. India Prilide Antihypertensive Drugs Sales by Players, (K Units), (2018-2023)
Table 26. India Prilide Antihypertensive Drugs Sales Share by Players, (2018-2023)
Table 27. Global Prilide Antihypertensive Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 28. Global Prilide Antihypertensive Drugs Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global Prilide Antihypertensive Drugs Sales in Volume Forecast by Region (2024-2034) & (K Units)
Table 30. Global Prilide Antihypertensive Drugs Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Prilide Antihypertensive Drugs Sales in Value Forecast by Region (2024-2034) & (US$ Million)
Table 32. Americas Prilide Antihypertensive Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. Americas Prilide Antihypertensive Drugs Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Prilide Antihypertensive Drugs Sales in Value by Country (2024-2034) & (US$ Million)
Table 35. Americas Prilide Antihypertensive Drugs Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas Prilide Antihypertensive Drugs Sales in Volume by Country (2024-2034) & (K Units)
Table 37. EMEA Prilide Antihypertensive Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. EMEA Prilide Antihypertensive Drugs Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Prilide Antihypertensive Drugs Sales in Value by Country (2024-2034) & (US$ Million)
Table 40. EMEA Prilide Antihypertensive Drugs Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA Prilide Antihypertensive Drugs Sales in Volume by Country (2024-2034) & (K Units)
Table 42. APAC Prilide Antihypertensive Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. APAC Prilide Antihypertensive Drugs Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Prilide Antihypertensive Drugs Sales in Value by Country (2024-2034) & (US$ Million)
Table 45. APAC Prilide Antihypertensive Drugs Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC Prilide Antihypertensive Drugs Sales in Volume by Country (2024-2034) & (K Units)
Table 47. Merck Company Information
Table 48. Merck Description and Business Overview
Table 49. Merck Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 50. Merck Prilide Antihypertensive Drugs Product
Table 51. Merck Recent Development
Table 52. Pfizer Company Information
Table 53. Pfizer Description and Business Overview
Table 54. Pfizer Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 55. Pfizer Prilide Antihypertensive Drugs Product
Table 56. Pfizer Recent Development
Table 57. Sanofi Company Information
Table 58. Sanofi Description and Business Overview
Table 59. Sanofi Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 60. Sanofi Prilide Antihypertensive Drugs Product
Table 61. Sanofi Recent Development
Table 62. Abbott Company Information
Table 63. Abbott Description and Business Overview
Table 64. Abbott Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 65. Abbott Prilide Antihypertensive Drugs Product
Table 66. Abbott Recent Development
Table 67. Novartis Company Information
Table 68. Novartis Description and Business Overview
Table 69. Novartis Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 70. Novartis Prilide Antihypertensive Drugs Product
Table 71. Novartis Recent Development
Table 72. Changzhou Pharmaceutical Company Information
Table 73. Changzhou Pharmaceutical Description and Business Overview
Table 74. Changzhou Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 75. Changzhou Pharmaceutical Prilide Antihypertensive Drugs Product
Table 76. Changzhou Pharmaceutical Recent Development
Table 77. Humanwell Pharmaceutical Company Information
Table 78. Humanwell Pharmaceutical Description and Business Overview
Table 79. Humanwell Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 80. Humanwell Pharmaceutical Prilide Antihypertensive Drugs Product
Table 81. Humanwell Pharmaceutical Recent Development
Table 82. Hengcheng Pharmaceutical Company Information
Table 83. Hengcheng Pharmaceutical Description and Business Overview
Table 84. Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Product
Table 86. Hengcheng Pharmaceutical Recent Development
Table 87. Hengwei Pharmaceutical Company Information
Table 88. Hengwei Pharmaceutical Description and Business Overview
Table 89. Hengwei Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. Hengwei Pharmaceutical Prilide Antihypertensive Drugs Product
Table 91. Hengwei Pharmaceutical Recent Development
Table 92. Zhongfu Pharmaceutical Company Information
Table 93. Zhongfu Pharmaceutical Description and Business Overview
Table 94. Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Product
Table 96. Zhongfu Pharmaceutical Recent Development
Table 97. Likang Pharmaceutical Company Information
Table 98. Likang Pharmaceutical Description and Business Overview
Table 99. Likang Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. Likang Pharmaceutical Prilide Antihypertensive Drugs Product
Table 101. Likang Pharmaceutical Recent Development
Table 102. Changjiang Pharmaceutical Company Information
Table 103. Changjiang Pharmaceutical Description and Business Overview
Table 104. Changjiang Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 105. Changjiang Pharmaceutical Prilide Antihypertensive Drugs Product
Table 106. Changjiang Pharmaceutical Recent Development
Table 107. Baiyunshan Pharmaceutical Company Information
Table 108. Baiyunshan Pharmaceutical Description and Business Overview
Table 109. Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Product
Table 111. Baiyunshan Pharmaceutical Recent Development
Table 112. Poly Pharm Company Information
Table 113. Poly Pharm Description and Business Overview
Table 114. Poly Pharm Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. Poly Pharm Prilide Antihypertensive Drugs Product
Table 116. Poly Pharm Recent Development
Table 117. Lukang Group Company Information
Table 118. Lukang Group Description and Business Overview
Table 119. Lukang Group Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. Lukang Group Prilide Antihypertensive Drugs Product
Table 121. Lukang Group Recent Development
Table 122. Baili Pharmaceutical Company Information
Table 123. Baili Pharmaceutical Description and Business Overview
Table 124. Baili Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. Baili Pharmaceutical Prilide Antihypertensive Drugs Product
Table 126. Baili Pharmaceutical Recent Development
Table 127. Huahai Pharmaceutical Company Information
Table 128. Huahai Pharmaceutical Description and Business Overview
Table 129. Huahai Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 130. Huahai Pharmaceutical Prilide Antihypertensive Drugs Product
Table 131. Huahai Pharmaceutical Recent Development
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Prilide Antihypertensive Drugs Customers List
Table 135. Prilide Antihypertensive Drugs Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Prilide Antihypertensive Drugs Product Picture
Figure 2. Global Prilide Antihypertensive Drugs Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Prilide Antihypertensive Drugs Market Size 2018-2034 (US$ Million)
Figure 4. Global Prilide Antihypertensive Drugs Sales 2018-2034 (K Units)
Figure 5. India Prilide Antihypertensive Drugs Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 6. India Prilide Antihypertensive Drugs Market Size 2018-2034 (US$ Million)
Figure 7. India Prilide Antihypertensive Drugs Sales 2018-2034 (K Units)
Figure 8. India Prilide Antihypertensive Drugs Market Share in Global, in Value (US$ Million) 2018-2034
Figure 9. India Prilide Antihypertensive Drugs Market Share in Global, in Volume (K Units) 2018-2034
Figure 10. Prilide Antihypertensive Drugs Report Years Considered
Figure 11. Product Picture of Captopril
Figure 12. Product Picture of Enalapril
Figure 13. Product Picture of Lisinopril
Figure 14. Product Picture of Fosinopril
Figure 15. Product Picture of Others
Figure 16. Global Prilide Antihypertensive Drugs Market Share by Type in 2024 & 2034
Figure 17. Global Prilide Antihypertensive Drugs Sales in Value by Type (2018-2034) & (US$ Million)
Figure 18. Global Prilide Antihypertensive Drugs Sales Market Share in Value by Type (2018-2034)
Figure 19. Global Prilide Antihypertensive Drugs Sales by Type (2018-2034) & (K Units)
Figure 20. Global Prilide Antihypertensive Drugs Sales Market Share in Volume by Type (2018-2034)
Figure 21. Global Prilide Antihypertensive Drugs Price by Type (2018-2034) & (US$/Unit)
Figure 22. India Prilide Antihypertensive Drugs Market Share by Type in 2024 & 2034
Figure 23. India Prilide Antihypertensive Drugs Sales in Value by Type (2018-2034) & (US$ Million)
Figure 24. India Prilide Antihypertensive Drugs Sales Market Share in Value by Type (2018-2034)
Figure 25. India Prilide Antihypertensive Drugs Sales by Type (2018-2034) & (K Units)
Figure 26. India Prilide Antihypertensive Drugs Sales Market Share in Volume by Type (2018-2034)
Figure 27. India Prilide Antihypertensive Drugs Price by Type (2018-2034) & (US$/Unit)
Figure 28. Product Picture of Hospital
Figure 29. Product Picture of Clinic
Figure 30. Global Prilide Antihypertensive Drugs Market Share by Application in 2024 & 2034
Figure 31. Global Prilide Antihypertensive Drugs Sales in Value by Application (2018-2034) & (US$ Million)
Figure 32. Global Prilide Antihypertensive Drugs Sales Market Share in Value by Application (2018-2034)
Figure 33. Global Prilide Antihypertensive Drugs Sales by Application (2018-2034) & (K Units)
Figure 34. Global Prilide Antihypertensive Drugs Sales Market Share in Volume by Application (2018-2034)
Figure 35. Global Prilide Antihypertensive Drugs Price by Application (2018-2034) & (US$/Unit)
Figure 36. India Prilide Antihypertensive Drugs Market Share by Application in 2024 & 2034
Figure 37. India Prilide Antihypertensive Drugs Sales in Value by Application (2018-2034) & (US$ Million)
Figure 38. India Prilide Antihypertensive Drugs Sales Market Share in Value by Application (2018-2034)
Figure 39. India Prilide Antihypertensive Drugs Sales by Application (2018-2034) & (K Units)
Figure 40. India Prilide Antihypertensive Drugs Sales Market Share in Volume by Application (2018-2034)
Figure 41. India Prilide Antihypertensive Drugs Price by Application (2018-2034) & (US$/Unit)
Figure 42. Americas Prilide Antihypertensive Drugs Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 43. Americas Prilide Antihypertensive Drugs Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 44. Americas Prilide Antihypertensive Drugs Sales by Type (2018-2034) & (K Units)
Figure 45. Americas Prilide Antihypertensive Drugs Sales Market Share in Volume by Type (2018-2034)
Figure 46. Americas Prilide Antihypertensive Drugs Sales by Application (2018-2034) & (K Units)
Figure 47. Americas Prilide Antihypertensive Drugs Sales Market Share in Volume by Application (2018-2034)
Figure 48. United States Prilide Antihypertensive Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 49. Canada Prilide Antihypertensive Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 50. Mexico Prilide Antihypertensive Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 51. Brazil Prilide Antihypertensive Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 52. EMEA Prilide Antihypertensive Drugs Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 53. EMEA Prilide Antihypertensive Drugs Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 54. EMEA Prilide Antihypertensive Drugs Sales by Type (2018-2034) & (K Units)
Figure 55. EMEA Prilide Antihypertensive Drugs Sales Market Share in Volume by Type (2018-2034)
Figure 56. EMEA Prilide Antihypertensive Drugs Sales by Application (2018-2034) & (K Units)
Figure 57. EMEA Prilide Antihypertensive Drugs Sales Market Share in Volume by Application (2018-2034)
Figure 58. Europe Prilide Antihypertensive Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 59. Middle East Prilide Antihypertensive Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 60. Africa Prilide Antihypertensive Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 61. China Prilide Antihypertensive Drugs Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 62. China Prilide Antihypertensive Drugs Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 63. China Prilide Antihypertensive Drugs Sales by Type (2018-2034) & (K Units)
Figure 64. China Prilide Antihypertensive Drugs Sales Market Share in Volume by Type (2018-2034)
Figure 65. China Prilide Antihypertensive Drugs Sales by Application (2018-2034) & (K Units)
Figure 66. China Prilide Antihypertensive Drugs Sales Market Share in Volume by Application (2018-2034)
Figure 67. APAC Prilide Antihypertensive Drugs Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 68. APAC Prilide Antihypertensive Drugs Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 69. APAC Prilide Antihypertensive Drugs Sales by Type (2018-2034) & (K Units)
Figure 70. APAC Prilide Antihypertensive Drugs Sales Market Share in Volume by Type (2018-2034)
Figure 71. APAC Prilide Antihypertensive Drugs Sales by Application (2018-2034) & (K Units)
Figure 72. APAC Prilide Antihypertensive Drugs Sales Market Share in Volume by Application (2018-2034)
Figure 73. Japan Prilide Antihypertensive Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 74. South Korea Prilide Antihypertensive Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 75. China Taiwan Prilide Antihypertensive Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 76. Southeast Asia Prilide Antihypertensive Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 77. India Prilide Antihypertensive Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 78. Prilide Antihypertensive Drugs Value Chain
Figure 79. Prilide Antihypertensive Drugs Production Process
Figure 80. Channels of Distribution
Figure 81. Distributors Profiles
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed